Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Navidea Biopharmaceuticals begins phase III registration program for NAV-5001

Dec. 4, 2013

Navidea to collaborate with UAB on study of RIGS monoclonal antibody targeting agent

Dec. 2, 2013

CSL Behring launches DNA1 Advanced Alpha-1 Screening test

Nov. 29, 2013

GE Healthcare develops Affibody-based radiotracer to assess HER2 status

Nov. 27, 2013

Trial shows promising results for SAPPHIRE II eye test designed to identify AD

Nov. 26, 2013

Arrayit enters agreement with Diagnostic Oncology Research Organization

Nov. 22, 2013

Vivione Biosciences enters into CRADA to expand the capability of RAPID-B

Nov. 22, 2013

Qiagen and Lilly in new agreement to develop companion diagnostic for oncology compound

Nov. 19, 2013

Cepheid presents early data for Xpert HPV test

Nov. 18, 2013

Navidea and UCSF collaborate on study of 99mTc-tilmanocept imaging in Kaposi's syndrome

Nov. 14, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...